Breaking News

Endo Appoints R&D Head

By Kristin Brooks | March 7, 2014

Hall brings 30 years of R&D experience

Susan Hall, Ph.D. has been appointed executive vice president, chief scientific officer and global head of R&D and quality, at Endo International plc. Dr. Hall will be based in Dublin, Ireland at the company's new global corporate headquarters.
 
Prior to joining the company, Dr. Hall served as senior vice president and global head of R&D at Valeant Pharmaceuticals International, where she led the company's product pipeline and life cycle management activities with responsibility for quality compliance. Dr. Hall has also held various leadership roles in R&D at GlaxoSmithKline including clinical pharmacology, project management, medical affairs, and regulatory affairs.
 
"We are thrilled that Sue has joined the Endo team as the progression of Endo to a leading specialty healthcare company continues," said Rajiv De Silva, president and chief executive officer of Endo. "Sue brings more than 30 years of extensive multi-disciplinary and international expertise in drug development and life cycle management across a broad range of therapeutic areas along with extensive experience in quality. R&D will continue to be a key part of Endo's future organic growth plans and Sue's experience and background make her an excellent fit for the role."

Related Contract Manufacturing:

Related Compliance:

  • When Quality Meets Confidence

    When Quality Meets Confidence

    Dr. Fadia AlKhalil, Vice President of Global Business Development for Laboratory Services, SGS ||November 9, 2016
    A look at global account management for R&D outsourcing

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus